1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. UNITED KINGDOM BIOPHOTONICS MARKET BY TECHNOLOGY
5.1. Introduction
5.2. Imaging Technologies
5.3. Spectroscopy Technologies
5.4. Light-Based Therapeutics
5.5. Biosensors and Bioassays
6. UNITED KINGDOM BIOPHOTONICS MARKET BY APPLICATION
6.1. Introduction
6.2. Medical Diagnostics
6.3. Therapeutics
6.4. Research and Development
6.5. Environmental Monitoring
7. UNITED KINGDOM BIOPHOTONICS MARKET BY END-USER
7.1. Introduction
7.2. Hospitals and Clinics
7.3. Research Institutions and Laboratories
7.4. Pharmaceutical and Biotechnology Companies
7.5. Environmental Agencies
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Thermo Fisher Scientific Inc.
9.2. Carl Zeiss AG
9.3. Leica Microsystems GmbH
9.4. HORIBA Ltd.
9.5. Hamamatsu Photonics K.K.
9.6. Olympus Corporation
9.7. Danaher Corporation
9.8. Thorlabs Inc.
9.9. Oxford Instruments plc
9.10. Edinburgh Instruments Ltd.
10. APPENDIX
10.1. Currency
10.2. Assumptions
10.3. Base and Forecast Years Timeline
10.4. Key benefits for the stakeholders
10.5. Research Methodology
10.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES